The stock had had quite the run-up in price before its slide. Investors were extremely satisfied with the fourth-quarter earnings report published in February.

Hims & Hers Health, Inc. (HIMS) closed the most recent trading day at $12.34, moving -0.56% from the previous trading session.

In the closing of the recent trading day, Hims & Hers Health, Inc. (HIMS) stood at $14.60, denoting a +0.34% change from the preceding trading day.

These stocks are reporting above-average growth rates in their respective industries and share prices are soaring. Hims & Hers Health is serving essential needs across diverse patient populations.

Younger generations need digital healthcare solutions. Hims' birth and ascent is a lesson in psychology. I disclose my original position of just under 50,000 shares at a cost basis of $5.50. I valu...

WW International Inc. NASDAQ: WW (WeightWatchers) has had a disastrous 2024, with its shares collapsing 66.7% year-to-date (YTD). The company made a praiseworthy strategic pivot in 2023, acquiring ...

Hims & Hers Health, Inc. has grown from a startup ($82m revenues in 2019) to a multi-billion-dollar company ($872m revenues in 2023) with more than 1.5 million subscribers; showcasing its scalabili...

GameStop (NYSE: GME ) and AMC Entertainment (NYSE: AMC ) saw their shares skyrocket in early 2021 after several Reddit users incited a rally. Investors may have largely lost interest in these two s...

Does Hims & Hers Health, Inc. (HIMS) have what it takes to be a top stock pick for momentum investors? Let's find out.

Hims & Hers Inc. NYSE: HIMS is a telehealth platform in the medical sector that has turned the corner into GAAP profitability. The company got its start offering convenient, frictionless and discre...

The shares of Hims & Hers Health (NYSE: HIMS), a direct-to-consumer telehealth company, have surged by more than 40% since the release of its Q4 earnings report and more than 50% since the start of...

Hims & Hers Health is up big on a blowout Q4 earnings report. The company is taking market share from competitors.

Hims & Hers Health, Inc. (HIMS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Investing in healthcare stocks may not seem very exciting. This group of low-beta stocks serves as a defensive area of the consumer staples sector without much growth or activity.

Shares of Shares of Hims & Hers Health popped Tuesday after the company reported better-than-expected quarterly results.